Theon Pharmaceuticals Ltd., a leading CDMO in India, has achieved a significant milestone in respiratory therapy with its ...

GLP-1 receptor agonists are new weight loss drugs that make you feel full longer. Stimulants like phentermine are widely used and can help reduce appetite. Diet pills such as lipase inhibitors slow ...

ROME—Pope Francis has developed pneumonia in both lungs, the Vatican said Tuesday, after new tests showed a further ...

MUSC researchers are tackling MASH, or metabolic dysfunction-associated steatohepatitis, a liver disease affecting hundreds ...

Keeping your skin well moisturized helps to prevent cracks and fissures in your skin that could lead to a worsening rash, itching, or infection. Where do signs, such as rashes or dryness and itch, ...

Javascript must be enabled to use this site. Please enable Javascript in your browser and try again. New! Access free and discounted resources from Nomorobo, a spam ...

The hotel ballroom was packed to near capacity with scientists when Susan Yanovski arrived. Despite being 10 minutes early, she had to manoeuvre her way to one of the few empty seats near the back.

Chronic obstructive pulmonary disease (COPD), which includes emphysema and chronic bronchitis, affects more than 30 million ...

On April 18, President Donald Trump signed an executive order intended to accelerate the development of psychedelic drugs as medical treatments. The order calls for the Food and Drug Administration ...

Javascript must be enabled to use this site. Please enable Javascript in your browser and try again. New! Access free and discounted resources from Nomorobo, a spam ...

President Trump has signed an executive order to ease research restrictions on psychedelics, including the drug ibogaine, which is used in some countries to treat post-traumatic stress disorder.

The president’s executive order is intended to accelerate research into the compounds’ efficacy in treating mental health disorders like severe depression and PTSD. By Andrew Jacobs and Noah Daly ...